Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Top Cited Papers
- 1 November 2015
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 217, 345-351
- https://doi.org/10.1016/j.jconrel.2015.08.007
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation CAVD (R01-AI-050484, R01-AI-090788)
This publication has 27 references indexed in Scilit:
- A Cationic Nanoemulsion for the Delivery of Next-generation RNA VaccinesMolecular Therapy, 2014
- Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle formatJournal of Controlled Release, 2013
- In Vitro Transcription of Long RNA Containing Modified NucleosidesPublished by Springer Nature ,2012
- Manual Restraint and Common Compound Administration Routes in Mice and RatsJournal of Visualized Experiments, 2012
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based MechanismsMolecular Therapy, 2010
- Lipid-like materials for low-dose, in vivo gene silencingProceedings of the National Academy of Sciences, 2010
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma PatientsJournal of Immunotherapy, 2009
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- A combinatorial library of lipid-like materials for delivery of RNAi therapeuticsNature Biotechnology, 2008
- Reversal of Diabetes Insipidus in Brattleboro Rats: Intrahypothalamic Injection of Vasopressin mRNAScience, 1992